EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cytologic features of pancreatic endocrine tumors islet cell tumors



Cytologic features of pancreatic endocrine tumors islet cell tumors



Acta Cytologica 28(5): 645-646




(PDF emailed within 1 workday: $29.90)

Accession: 028042363

Download citation: RISBibTeXText



Related references

Cytologic features of pancreatic acinar and islet cell tumors. Acta Cytologica 38(5): 858, 1994

Pancreatic islet cell tumors and their syndromes. II. Zollinger-Ellison syndrome, glucagonoma syndrome, multiple endocrine adenomatosis and islet cell tumors not obviously provable. Schweizerische Medizinische Wochenschrift 108(50): 1997-2007, 1978

Pancreatic oncocytic endocrine tumors. Cytologic features of two cases. Acta Cytologica 40(4): 742-746, 1996

Cytologic features of islet-cell tumors. Acta Cytologica 31(4): 485-492, 1987

Cystic islet cell tumors: Clinical, radiologic, cytologic, and histologic features. 2005

Endocrine syndromes associated with pancreatic islet cell tumors. Medical Clinics of North America 52(2): 295-312, 1968

A case of familial multiple endocrine neoplasia men type i with multiple pancreatic islet cell tumors and multiple parathyroid tumors. Journal of the Japan Diabetes Society 34(3): 251-257, 1991

Clinical syndromes associated with pancreatic islet cell endocrine tumors. Contemporary Surgery: 13-16, 25-27, 1987

Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1. Surgery (st Louis). 122(6): 1012-1020,., 1997

Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1. Surgery 122(6): 1012-9; Discussion 1019-20, 1998

Morphology and immuno histochemically defined endocrine function of pancreatic islet cell tumors. Histopathology (Oxford) 2(6): 389-400, 1978

Clinics on endocrine and metabolic diseases. 3. Hyperinsulinism: review of 95 cases of functioning pancreatic islet cell tumors. Proceedings of the Staff Meetings. Mayo Clinic 35: 545-550, 1960

PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors. American Journal of Surgical Pathology 34(5): 723-729, 2010

KIT is an independent prognostic marker for pancreatic endocrine tumors: a finding derived from analysis of islet cell differentiation markers. American Journal of Surgical Pathology 33(10): 1562-1569, 2010

Studies in vivo and in vitro on chemically induced primary islet cell tumors and nontumor endocrine pancreatic tissue. Diabetologia 24(1): 30-37, 1983